New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis
Author(s) -
Katarzyna Krzyzanowska-Mittermayer,
Anders Mattsson,
Dominique Maiter,
Ulla FeldtRasmussen,
Cecilia CamachoHübner,
Anton Luger,
Roger Abs
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-01899
Subject(s) - ighd , medicine , incidence (geometry) , malignancy , confidence interval , pituitary adenoma , gastroenterology , growth hormone deficiency , population , cancer , neoplasm , adenoma , pediatrics , endocrinology , hormone , growth hormone , pathology , physics , environmental health , optics
Data on the association between growth hormone (GH) replacement in patients with GH deficiency (GHD) after malignancies and new neoplasms show conflicting results.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom